FXH logo

First Trust Health Care AlphaDEX Fund (FXH)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

First Trust Health Care AlphaDEX Fund (FXH) with AI Score 44/100 (Weak). First Trust Health Care AlphaDEX Fund (FXH) is an exchange-traded fund that aims to mirror the performance of the StrataQuant Health Care Index. Market cap: 0, Sector: Financial services.

Last analyzed: Mar 18, 2026
First Trust Health Care AlphaDEX Fund (FXH) is an exchange-traded fund that aims to mirror the performance of the StrataQuant Health Care Index. The fund provides investors exposure to the healthcare sector through a quantitative methodology.
44/100 AI Score

First Trust Health Care AlphaDEX Fund (FXH) Financial Services Profile

IPO Year2007

First Trust Health Care AlphaDEX Fund (FXH) offers investors targeted exposure to the healthcare sector through a quantitative index-tracking strategy. With approximately $0.93 billion in assets, FXH differentiates itself by utilizing the StrataQuant Health Care Index, focusing on companies within the healthcare industry based on growth and value factors.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 18, 2026

Investment Thesis

First Trust Health Care AlphaDEX Fund (FXH) presents a targeted investment vehicle for those seeking exposure to the healthcare sector. With a market capitalization of $0.93 billion, FXH offers a relatively liquid option for investors. The fund's investment thesis rests on its ability to track the StrataQuant Health Care Index, which uses a quantitative methodology to select and weight healthcare stocks based on growth and value factors. A potential catalyst for FXH is the continued growth and innovation within the healthcare industry, driven by factors such as an aging population, technological advancements, and increasing healthcare spending. However, potential risks include regulatory changes, patent expirations, and economic downturns that could impact the healthcare sector. The fund's expense ratio and tracking error relative to its index should be closely monitored.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $0.93 billion, indicating a mid-sized ETF within the healthcare sector.
  • Tracks the StrataQuant Health Care Index, employing a quantitative methodology to select and weight holdings.
  • Provides exposure to a diversified basket of healthcare stocks across various sub-sectors.
  • Offers intraday liquidity, allowing investors to buy or sell shares throughout the trading day.
  • Managed by First Trust Advisors L.P., a well-established provider of ETFs and other investment products.

Competitors & Peers

Strengths

  • Quantitatively driven investment approach.
  • Diversified exposure to the healthcare sector.
  • ETF structure provides liquidity and transparency.
  • Managed by an experienced asset management firm.

Weaknesses

  • Reliance on the performance of the StrataQuant Health Care Index.
  • Vulnerability to regulatory changes in the healthcare sector.
  • Potential for tracking error relative to the index.
  • Subject to market volatility and economic downturns.

Catalysts

  • Ongoing: Continued growth and innovation within the healthcare industry.
  • Ongoing: Increasing adoption of ETFs among investors.
  • Upcoming: Potential for new drug approvals and medical breakthroughs.
  • Upcoming: Positive regulatory developments in the healthcare sector.

Risks

  • Potential: Regulatory changes and healthcare policy reforms.
  • Potential: Patent expirations and generic competition.
  • Potential: Economic downturns and reduced healthcare spending.
  • Ongoing: Market volatility and fluctuations in asset values.
  • Ongoing: Competition from other asset management firms and investment products.

Growth Opportunities

  • Expansion of Healthcare Sector: The healthcare sector is projected to experience substantial growth, driven by an aging global population and advancements in medical technology. This growth presents a significant opportunity for FXH, as increased investment in healthcare companies could lead to higher asset values within the fund. The global healthcare market is expected to reach trillions of dollars in the coming years, providing a substantial runway for growth. Timeline: Ongoing.
  • Increased Adoption of ETFs: Exchange-traded funds (ETFs) have gained popularity among investors due to their low cost, transparency, and liquidity. As more investors allocate capital to ETFs, FXH stands to benefit from increased inflows. The global ETF market is projected to continue its expansion, offering FXH a larger pool of potential investors. Timeline: Ongoing.
  • Innovation in Healthcare: The healthcare industry is undergoing rapid innovation, with new drugs, medical devices, and healthcare technologies being developed at an accelerated pace. FXH's quantitative methodology may allow it to identify and invest in companies that are at the forefront of these innovations, potentially leading to higher returns. Timeline: Ongoing.
  • Strategic Partnerships: FXH could explore strategic partnerships with healthcare organizations or research institutions to gain access to proprietary data and insights. These partnerships could enhance the fund's ability to identify promising investment opportunities and improve its overall performance. Timeline: 1-3 years.
  • Geographic Expansion: While FXH primarily focuses on healthcare companies listed in the United States, it could consider expanding its investment universe to include international healthcare companies. This would provide investors with greater diversification and exposure to different healthcare markets around the world. Timeline: 3-5 years.

Opportunities

  • Growth in the healthcare sector driven by demographic trends and technological advancements.
  • Increasing adoption of ETFs among investors.
  • Potential for strategic partnerships with healthcare organizations.
  • Expansion into international healthcare markets.

Threats

  • Intense competition from other asset management firms.
  • Changes in investor sentiment towards the healthcare sector.
  • Economic downturns that could impact healthcare spending.
  • Regulatory changes that could negatively affect healthcare companies.

Competitive Advantages

  • Established brand and reputation of First Trust Advisors L.P.
  • Proprietary StrataQuant Health Care Index methodology.
  • Diversified portfolio of healthcare stocks.
  • ETF structure provides liquidity and transparency.

About FXH

The First Trust Health Care AlphaDEX Fund (FXH) is an exchange-traded fund (ETF) designed to replicate the price and yield performance of the StrataQuant Health Care Index, before accounting for fees and expenses. Launched to provide investors with a focused approach to the healthcare sector, FXH employs a quantitative methodology to select and weight its holdings. The fund's underlying index utilizes a variety of growth and value factors to identify healthcare companies with the potential for above-average returns. FXH's strategy involves ranking eligible healthcare companies based on these factors and then constructing a portfolio that reflects the index's composition. This approach aims to outperform traditional market-cap-weighted healthcare indices. The fund's holdings span various sub-sectors within healthcare, including pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. By providing exposure to a diversified basket of healthcare stocks, FXH seeks to offer investors a convenient and cost-effective way to participate in the growth of the healthcare industry. As an ETF, FXH offers intraday liquidity, allowing investors to buy or sell shares throughout the trading day. The fund is managed by First Trust Advisors L.P., a well-established provider of ETFs and other investment products.

What They Do

  • Tracks the performance of the StrataQuant Health Care Index.
  • Invests in a diversified portfolio of healthcare stocks.
  • Employs a quantitative methodology to select and weight holdings.
  • Provides investors with exposure to various sub-sectors within healthcare.
  • Offers intraday liquidity through its ETF structure.
  • Manages assets on behalf of individual and institutional investors.
  • Seeks to provide investment results that correspond generally to the price and yield of its underlying index.

Business Model

  • Generates revenue through management fees charged on assets under management (AUM).
  • AUM fluctuates based on market performance and investor inflows/outflows.
  • Expense ratio covers operational costs, including management fees, administrative expenses, and other fees.
  • Profitability depends on the fund's ability to attract and retain assets while controlling expenses.

Industry Context

The asset management industry is characterized by intense competition, with numerous firms offering a wide range of investment products, including ETFs. The healthcare sector, in particular, has attracted significant investor interest due to its growth potential and defensive characteristics. FXH operates within this landscape by providing a quantitatively driven approach to healthcare investing. The fund's success depends on its ability to effectively track its underlying index and deliver competitive returns relative to other healthcare ETFs and mutual funds. Market trends such as increasing healthcare spending and technological advancements in medicine are expected to continue driving growth in the healthcare sector.

Key Customers

  • Individual investors seeking exposure to the healthcare sector.
  • Financial advisors looking for diversified investment options for their clients.
  • Institutional investors, including pension funds, endowments, and foundations.
  • High-net-worth individuals seeking specialized investment strategies.
AI Confidence: 71% Updated: Mar 18, 2026

Financials

Chart & Info

First Trust Health Care AlphaDEX Fund (FXH) stock price: Price data unavailable

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FXH.

Price Targets

Wall Street price target analysis for FXH.

MoonshotScore

44/100

What does this score mean?

The MoonshotScore rates FXH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

FXH Financial Services Stock FAQ

What does First Trust Health Care AlphaDEX Fund do?

First Trust Health Care AlphaDEX Fund (FXH) is an exchange-traded fund designed to track the performance of the StrataQuant Health Care Index. The fund invests in a diversified portfolio of healthcare stocks, utilizing a quantitative methodology to select and weight its holdings. FXH aims to provide investors with exposure to various sub-sectors within the healthcare industry, including pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. By tracking the StrataQuant Health Care Index, the fund seeks to deliver investment results that correspond generally to the price and yield of the index, before accounting for fees and expenses. The fund is managed by First Trust Advisors L.P.

What do analysts say about FXH stock?

AI analysis is pending for FXH. Generally, analysts evaluate ETFs like FXH based on factors such as the underlying index's performance, expense ratio, tracking error, and the overall outlook for the healthcare sector. Key valuation metrics include the fund's net asset value (NAV) and its premium or discount to NAV. Growth considerations typically focus on the potential for increased assets under management (AUM) and the fund's ability to attract and retain investors. Analyst ratings and price targets may vary depending on their individual investment perspectives and methodologies. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions.

What are the main risks for FXH?

The main risks for FXH include regulatory changes in the healthcare sector, which could impact the profitability and growth prospects of healthcare companies. Patent expirations and generic competition pose a risk to pharmaceutical companies within the fund's portfolio. Economic downturns could lead to reduced healthcare spending, affecting the financial performance of healthcare providers and suppliers. Market volatility and fluctuations in asset values could also negatively impact the fund's performance. Additionally, FXH faces competition from other asset management firms and investment products, which could lead to investor outflows and reduced AUM.

What are the key factors to evaluate for FXH?

First Trust Health Care AlphaDEX Fund (FXH) currently holds an AI score of 44/100, indicating low score. Key strength: Quantitatively driven investment approach.. Primary risk to monitor: Potential: Regulatory changes and healthcare policy reforms.. This is not financial advice.

How frequently does FXH data refresh on this page?

FXH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven FXH's recent stock price performance?

Recent price movement in First Trust Health Care AlphaDEX Fund (FXH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Quantitatively driven investment approach.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider FXH overvalued or undervalued right now?

Determining whether First Trust Health Care AlphaDEX Fund (FXH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying FXH?

Before investing in First Trust Health Care AlphaDEX Fund (FXH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • AI analysis pending for FXH.
  • The information provided is based on available data and may be subject to change.
  • Investors should conduct their own due diligence before making any investment decisions.
Data Sources

Popular Stocks